SV Life Sciences closes fourth fund on $572m
SV Life Sciences has closed its fourth fund on $572m, just under the £300m fund that Abingworth closed last month but far exceeding its original target of $400m.
SV Life Sciences has closed its fourth fund on $572m, just under the £300m fund that Abingworth closed last month but far exceeding its original target of $400m.
Copyright PEI Media
Not for publication, email or dissemination